Strides' anti-bacterial injection receives FDA approval

10/3/2011 | Economic Times (India), The

The FDA authorized Strides Arcolab's Clindamycin Injection USP to treat bacterial infection. This marks the 12th drug approval under Strides' marketing collaboration with Sagent Pharmaceuticals. The drug will be launched early next year in single-use and bulk-pack vials, Strides said.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN